| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.094 | 0.04 |